AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Thermodynamic energy exchange in a moving plate capacitor
Authors: Davis, BR Abbott, D Parrondo, JMR
Citation: Br. Davis et al., Thermodynamic energy exchange in a moving plate capacitor, CHAOS, 11(3), 2001, pp. 747-754
Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Authors: Pressel, SL Davis, BR Wright, JT Geraci, TS Kingry, C Ford, CE Piller, LB Bettencourt, J Kimmel, B Lusk, C Parks, H Simpson, LM Nwachuku, C Furberg, CD
Citation: Sl. Pressel et al., Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), CONTR CL TR, 22(1), 2001, pp. 29-41
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Authors: Barzilay, JI Jones, CL Davis, BR Basile, JN Goff, DC Ciocon, JO Sweeney, ME Randall, OS
Citation: Ji. Barzilay et al., Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), DIABET CARE, 24(4), 2001, pp. 654-658
Power spectral density of road profiles
Authors: Davis, BR Thompson, AG
Citation: Br. Davis et Ag. Thompson, Power spectral density of road profiles, VEH SYST D, 35(6), 2001, pp. 409-415
Force control in electrohydraulic active suspensions revisited
Authors: Thompson, AG Davis, BR
Citation: Ag. Thompson et Br. Davis, Force control in electrohydraulic active suspensions revisited, VEH SYST D, 35(3), 2001, pp. 217-222
Undergraduates must learn to communicate ...
Authors: Watson, DA Davis, BR Niesel, DW
Citation: Da. Watson et al., Undergraduates must learn to communicate ..., NATURE, 411(6841), 2001, pp. 992-992
Reduction of stroke events with pravastatin - The Prospective Pravastatin Pooling (PPP) Project
Authors: Byington, RP Davis, BR Plehn, JF White, HD Baker, J Cobbe, SM Shepherd, J
Citation: Rp. Byington et al., Reduction of stroke events with pravastatin - The Prospective Pravastatin Pooling (PPP) Project, CIRCULATION, 103(3), 2001, pp. 387-392
Multicenter Trial of Cryotherapy for Retinopathy of Prematurity - Ophthalmological outcomes at 10 years
Authors: Elsas, FJ Collins, M Jones, J Kimble, JA Kline, L Witherspoon, D Roth, AM Demorest, BH Gilbert, WS Plotsky, D Jaafar, M Pilkerton, AR Mercer, PA Siatkowski, RM Clarkson, J Johnson, RA Simon, J Zobal-Ratner, J Miller, MT Cronin, C Daily, M Kaufman, LM Mittelman, D Santiago, N Shapiro, M Skuran, K Squires, P Vygantas, C Ellis, FD Bates, D Helveston, EM Barr, CC Douglas, CH Fishman, PH Whittington, GK Gordon, RA Diamond, JG Neff, D Repka, MX Haller, JA Kraft, SP Mattheu, J Baker, JD Trese, MT Droste, PJ Manatrey, P Roarty, J Summers, CG Knobloch, DK Lavoie, JD Ramsay, RC Young, TL Phelps, DL Camarda, H Guillet, E Olsen, R Tingley, D Wood, N Hampton, R Merriam, W Reynolds, JD Awner, S Buckley, EG Anderson, MM Burke, MJ Johnson, JC Rogers, GL Bremer, DL Fellows, RR Letson, AD McClead, RE McGregor, MLK Palmer, EA Bartholomew, P Quinn, GE Brown, GC Hertle, RW Kubacki, JJ Menacker, SJ Miller, DL Schaffer, DB Tasman, W Wilson, MC Cheng, KF Biglan, AW Davis, JS Schramm, M Saunders, RA Bluestein, E Donahue, SP Law, AB Sinatra, R Steele, S Spencer, R Arnwine, J Berry, PM Leffler, JN Stager, DR van Heuven, WAJ Lee, BL Montez, MG Hoffman, RO Bracken, S Jordan, A Teske, M Everett, DF Palmer, EA Krom, CP Newton, S Okawa, S Beaudet, K Hardy, RJ Davis, BR Tung, B Dobson, V Quinn, GE Gidlewski, N Myers, V Harvey, E
Citation: Fj. Elsas et al., Multicenter Trial of Cryotherapy for Retinopathy of Prematurity - Ophthalmological outcomes at 10 years, ARCH OPHTH, 119(8), 2001, pp. 1110-1118
The Hypertension Detection and Follow-Up Program
Authors: Davis, BR Ford, CE
Citation: Br. Davis et Ce. Ford, The Hypertension Detection and Follow-Up Program, CLINICAL TRIALS IN HYPERTENSION, 2001, pp. 27-60
Rationale and design for the antihypertensive and lipid-lowering treatmentto prevent heart attack trial (ALLHAT)
Authors: Cutler, JA Gordon, DJ Davis, BR Wright, JT Furberg, CD
Citation: Ja. Cutler et al., Rationale and design for the antihypertensive and lipid-lowering treatmentto prevent heart attack trial (ALLHAT), CLINICAL TRIALS IN HYPERTENSION, 2001, pp. 531-586
Least squares estimation of variance components for linkage
Authors: Amos, CI Gu, XJ Chen, JF Davis, BR
Citation: Ci. Amos et al., Least squares estimation of variance components for linkage, GENET EPID, 19, 2000, pp. S1-S7
Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke - The Systolic Hypertension in the Elderly Program (SHEP)
Authors: Perry, HM Davis, BR Price, TR Applegate, WB Fields, WS Guralnik, JM Kuller, L Pressel, S Stamler, J Probstfield, JL
Citation: Hm. Perry et al., Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke - The Systolic Hypertension in the Elderly Program (SHEP), J AM MED A, 284(4), 2000, pp. 465-471
Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone - The Antihypertensive and Lipid-Lowering Treatment toPrevent Heart Attack Trial (ALLHAT)
Authors: Furberg, CD Wright, JT Davis, BR Cutler, JA Alderman, M Black, H Cushman, W Grimm, R Haywood, LJ Leenen, F Oparil, S Perry, HM Probstfield, J Whelton, P Payne, G Nwachuku, C Gordon, D Proschan, M Frommer, P Einhorn, P Hawkins, M Ford, C Pressel, S Piller, L Lusk, C Bettencourt, J Kimmel, B Geraci, T Walsh, S Rahman, M Juratovac, A Pospisil, R Brennan, K Carroll, L Sullivan, S Barone, G Christian, R Feldman, S Lucente, T Lewis, CE Jenkins, K McDowell, P Johnson, J Kingry, C Letterer, R Margolis, K Holland, L Jaeger-Fox, B Williamson, J Louis, G Ragusa, P Williard, A Ferguson, RS Tanner, J Eckfeldt, J Crow, R Pelosi, J
Citation: Cd. Furberg et al., Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone - The Antihypertensive and Lipid-Lowering Treatment toPrevent Heart Attack Trial (ALLHAT), J AM MED A, 283(15), 2000, pp. 1967-1975
Technical note: RMS values for control force, suspension stroke and tyre deflection in an active suspension
Authors: Thompson, AG Davis, BR
Citation: Ag. Thompson et Br. Davis, Technical note: RMS values for control force, suspension stroke and tyre deflection in an active suspension, VEH SYST D, 34(2), 2000, pp. 143-150
Glass needle-mediated microinjection of macromolecules and transgenes intoprimary human blood stem/progenitor cells
Authors: Davis, BR Yannariello-Brown, J Prokopishyn, NL Luo, ZJ Smith, MR Wang, J Carsrud, NDV Brown, DB
Citation: Br. Davis et al., Glass needle-mediated microinjection of macromolecules and transgenes intoprimary human blood stem/progenitor cells, BLOOD, 95(2), 2000, pp. 437-444
Cholesterol and recurrent events trial (CARE) - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
Authors: Sacks, FM Pfeffer, MA Moye, LA Hawkins, CM Davis, BR Rouleau, JL Cole, TG Braunwald, E
Citation: Fm. Sacks et al., Cholesterol and recurrent events trial (CARE) - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 63-89
Microcatheter adhesion of cyanoacrylates: Comparison of normal butyl cyanoacrylate to 2-hexyl cyanoacrylate
Authors: Barr, JD Hoffman, EJ Davis, BR Edgar, KA Jacobs, CR
Citation: Jd. Barr et al., Microcatheter adhesion of cyanoacrylates: Comparison of normal butyl cyanoacrylate to 2-hexyl cyanoacrylate, J VAS INT R, 10(2), 1999, pp. 165-168
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations
Authors: Flaker, GC Warnica, JW Sacks, FM Moye, LA Davis, BR Rouleau, JL Webel, RR Pfeffer, MA Braunwald, E
Citation: Gc. Flaker et al., Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations, J AM COL C, 34(1), 1999, pp. 106-112
The contribution of the ossific nucleus to the structural stiffness of thecapital femoral epiphysis: A porcine model for DDH
Authors: Segal, LS Schneider, DJ Berlin, JM Bruno, A Davis, BR Jacobs, CR
Citation: Ls. Segal et al., The contribution of the ossific nucleus to the structural stiffness of thecapital femoral epiphysis: A porcine model for DDH, J PED ORTH, 19(4), 1999, pp. 433-437
Isolated systolic hypertension - Prognostic information provided by pulse pressure
Authors: Domanski, MJ Davis, BR Pfeffer, MA Kastantin, M Mitchell, GF
Citation: Mj. Domanski et al., Isolated systolic hypertension - Prognostic information provided by pulse pressure, HYPERTENSIO, 34(3), 1999, pp. 375-380
The design of the multicenter study of light reduction in retinopathy of prematurity (LIGHT-ROP)
Authors: Reynolds, JD Gordon, DC Awner, S Seligson, MS Hardy, RJ Davis, BR Tung, B Ingerslew, S Kennedy, KA Spencer, R Donahue, LA Weakley, DR Wilson, CA Vallar, R Hakimian, N Kirby, J Van Heuven, WAJ Gong, AK von Schulenburg, E Cleland, TP Lee, BL Marouf, LM Fielder, AR Moseley, MJ Everett, DF Connett, J Palmer, EA Phelps, DL Tonascia, J MacKinnon, B Bobinski, MA
Citation: Jd. Reynolds et al., The design of the multicenter study of light reduction in retinopathy of prematurity (LIGHT-ROP), J PEDIAT OP, 36(5), 1999, pp. 257-263
The impact of boundary conditions and mesh size on the accuracy of cancellous bone tissue modulus determination using large-scale finite-element modeling
Authors: Jacobs, CR Davis, BR Rieger, CJ Francis, JJ Saad, M Fyhrie, DP
Citation: Cr. Jacobs et al., The impact of boundary conditions and mesh size on the accuracy of cancellous bone tissue modulus determination using large-scale finite-element modeling, J BIOMECHAN, 32(11), 1999, pp. 1159-1164
Reduction of stroke incidence after myocardial infarction with pravastatin- The cholesterol and recurrent events (CARE) study
Authors: Plehn, JF Davis, BR Sacks, FM Rouleau, JL Pfeffer, MA Bernstein, V Cuddy, TE Moye, LA Piller, LB Rutherford, J Simpson, LM Braunwald, E
Citation: Jf. Plehn et al., Reduction of stroke incidence after myocardial infarction with pravastatin- The cholesterol and recurrent events (CARE) study, CIRCULATION, 99(2), 1999, pp. 216-223
Baseline cholesterol level and magnitude of coronary event reduction in diabetic patients with myocardial infarction - Response
Authors: Sacks, FM Pfeffer, MA Braunwald, E Goldberg, RB Mellies, MJ Moye, LA Davis, BR Howard, BV Howard, WJ Cole, TG
Citation: Fm. Sacks et al., Baseline cholesterol level and magnitude of coronary event reduction in diabetic patients with myocardial infarction - Response, CIRCULATION, 100(25), 1999, pp. E154-E154
Differential effect of steady versus oscillating flow on bone cells
Authors: Jacobs, CR Yellowley, CE Davis, BR Zhou, Z Cimbala, JM Donahue, HJ
Citation: Cr. Jacobs et al., Differential effect of steady versus oscillating flow on bone cells, J BIOMECHAN, 31(11), 1998, pp. 969-976
Risultati: 1-25 | 26-26